Dakota Wealth Management Increases Position in Lam Research Corporation $LRCX

Dakota Wealth Management lifted its holdings in Lam Research Corporation (NASDAQ:LRCX) by 195.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 28,731 shares of the semiconductor company’s stock after buying an additional 18,992 shares during the quarter. Dakota Wealth Management’s holdings in Lam Research were worth $4,918,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. PMV Capital Advisers LLC purchased a new position in Lam Research during the 4th quarter valued at $25,000. Stance Capital LLC purchased a new stake in Lam Research in the third quarter worth $26,000. Howard Hughes Medical Institute bought a new stake in shares of Lam Research during the second quarter worth $27,000. Triumph Capital Management bought a new stake in shares of Lam Research during the third quarter worth $27,000. Finally, Strategic Wealth Investment Group LLC purchased a new stake in shares of Lam Research during the second quarter valued at $29,000. 84.61% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on LRCX shares. Bank of America upped their price target on shares of Lam Research from $195.00 to $245.00 and gave the stock a “buy” rating in a report on Tuesday, January 13th. The Goldman Sachs Group set a $262.00 price objective on shares of Lam Research and gave the company a “buy” rating in a research report on Thursday, January 29th. Morgan Stanley upped their target price on shares of Lam Research from $244.00 to $254.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 25th. Citigroup raised their target price on shares of Lam Research from $265.00 to $300.00 and gave the stock a “buy” rating in a research report on Thursday, January 29th. Finally, Barclays lifted their price target on shares of Lam Research from $250.00 to $255.00 and gave the company an “equal weight” rating in a research note on Tuesday, March 10th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, Lam Research currently has a consensus rating of “Moderate Buy” and a consensus price target of $245.35.

Insiders Place Their Bets

In other Lam Research news, Director Eric Brandt sold 35,000 shares of the stock in a transaction on Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the sale, the director owned 253,705 shares of the company’s stock, valued at approximately $57,235,848. This trade represents a 12.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Douglas R. Bettinger sold 50,057 shares of the business’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total value of $11,214,269.71. Following the completion of the transaction, the chief financial officer directly owned 1,081,705 shares of the company’s stock, valued at approximately $242,334,371.15. The trade was a 4.42% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 130,886 shares of company stock worth $29,658,802 over the last 90 days. Company insiders own 0.31% of the company’s stock.

Lam Research Stock Down 0.1%

NASDAQ:LRCX opened at $211.41 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $256.68. The company has a 50-day moving average of $227.81 and a 200 day moving average of $181.35. The firm has a market cap of $264.00 billion, a PE ratio of 43.32, a price-to-earnings-growth ratio of 2.28 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The business had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter last year, the firm posted $0.91 EPS. The company’s revenue for the quarter was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, research analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be paid a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a yield of 0.5%. Lam Research’s payout ratio is 21.31%.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.